RS THOUGHTS !!How important is it to " MANAGEMENT " to get the RS done before the Nov.18 Ad comm. decision is reported, if that's what they want.
Is our SP being held back till after the RS is done & the Adcomm report is issued ?
What difference does it make if any ?
Who will benefit the most from a RS ? ( option holders can't lose, they"ll just re-issue new ones )
I still get the feeling that SOMEBODY is trying to squeese out the little SH.
I'm O.K. with a RS and a NASDAQ listing, but not until after the FDA decision is handed down in Feb/16. JMHO & GLTAL